Black Caraway Seeds (Nigella sativa)

Black caraway seeds (Nigella sativa) contain thymoquinone as their primary bioactive compound, which drives most observed therapeutic effects through antioxidant, anti-inflammatory, and immunomodulatory mechanisms. Thymoquinone inhibits NF-κB signaling, scavenges free radicals, and modulates prostaglandin synthesis, giving the seed its broad pharmacological profile documented across cell, animal, and limited human studies.

Origin & History

Nigella sativa, commonly known as black caraway or black cumin, is a flowering plant native to South Asia whose small black seeds are extracted from seed pods and used medicinally and culinarily. The seeds contain 32-40% essential oil rich in bioactive compounds, with thymoquinone comprising 35-38% of the volatile oil extracts.

Historical & Cultural Context

The research dossier does not contain specific information about traditional medicine applications or historical use of Nigella sativa in traditional systems such as Ayurveda, Traditional Chinese Medicine, or Unani medicine.

Health Benefits

• Contains potent antioxidant compounds including thymoquinone, carvacrol, and trans-anethole (evidence quality: in-vitro studies only)
• Demonstrates cytotoxic activity against various tumor types through thymoquinone and dithymoquinone (evidence quality: laboratory studies only)
• May support inflammatory conditions through carvacrol's inhibition of human neutrophil elastase (evidence quality: preliminary enzymatic studies)
• Exhibits antimicrobial properties (evidence quality: referenced but not detailed)
• Rich source of minerals including iron, calcium, potassium, zinc, and phosphorus (evidence quality: compositional analysis)

How It Works

Thymoquinone, the dominant bioactive in Nigella sativa volatile oil, suppresses NF-κB transcription factor activation, thereby reducing downstream production of pro-inflammatory cytokines including TNF-α, IL-1β, and IL-6. It also inhibits cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) enzymes, limiting prostaglandin E2 and leukotriene synthesis. Additionally, thymoquinone and dithymoquinone induce apoptosis in tumor cell lines by activating caspase-3 and caspase-9 cascades while downregulating anti-apoptotic Bcl-2 protein expression.

Scientific Research

The provided research dossier does not include specific human clinical trials, randomized controlled trials, or meta-analyses with PMIDs. The available evidence consists primarily of chemical composition studies and in-vitro research on isolated compounds.

Clinical Summary

Human trials on Nigella sativa are generally small, with most randomized controlled trials enrolling between 40 and 100 participants and running 8–12 weeks. A 2013 meta-analysis found supplementation (1–3 g/day of seed oil or powder) modestly reduced fasting blood glucose and HbA1c in type 2 diabetic patients, though effect sizes were heterogeneous across studies. Several RCTs report reductions in systolic blood pressure of approximately 2–4 mmHg with 2.5 mL/day of black seed oil over 8 weeks, though these findings require replication in larger cohorts. Overall evidence quality is promising but limited by small sample sizes, inconsistent dosing, and lack of long-term safety data in humans.

Nutritional Profile

Per 100g of Nigella sativa seeds: Energy ~400 kcal; Protein 16–20g (rich in essential amino acids including glutamate, arginine, and aspartate); Fat 28–40g (predominantly unsaturated — linoleic acid (C18:2 omega-6) ~50–60% of total fatty acids, oleic acid (C18:1 omega-9) ~20–25%, palmitic acid ~12–14%, stearic acid ~3–4%; total unsaturated fatty acids typically >80% of fat content); Carbohydrates 25–35g; Dietary fiber 8–14g (significant insoluble fraction); Ash 3.7–5.0g. MINERALS: Calcium 186–570mg, Iron 11–18mg, Potassium 500–750mg, Magnesium 260–350mg, Phosphorus 430–550mg, Zinc 4.5–7.5mg, Sodium 17–85mg, Copper 1.2–1.8mg, Manganese 1.0–1.5mg, Selenium ~30–36µg. VITAMINS: Thiamine (B1) 0.63–1.5mg, Riboflavin (B2) 0.05–0.1mg, Niacin (B3) 4.5–5.7mg, Pyridoxine (B6) 0.50–0.67mg, Folate 36–85µg, Vitamin E (tocopherols, primarily γ-tocopherol) 7–25mg, Vitamin A (as carotenoids) trace amounts. KEY BIOACTIVE COMPOUNDS: Thymoquinone (TQ) 0.5–3.0% of seed weight (primary pharmacologically active compound; bioavailability is limited due to poor water solubility — lipid-based formulations and co-administration with piperine or fats may enhance absorption significantly); Thymohydroquinone; Dithymoquinone (nigellone) ~trace–0.2%; Thymol 0.03–0.1%; Carvacrol 0.05–0.3%; p-Cymene 7–15% of volatile oil; α-Pinene 0.5–2.5% of volatile oil; trans-Anethole ~1–4% of volatile oil; Longifolene; Nigellidine and nigellicine (indazole alkaloids, trace); Nigellamine A1–A5 (lipase-inhibiting diterpenes, trace). Essential/volatile oil content 0.4–2.5% of seed weight. Fixed oil content 28–40% of seed weight, rich in phytosterols (β-sitosterol ~44–54%, stigmasterol ~6–16%, campesterol ~3–5%; total phytosterols ~1,000–2,500mg/100g oil). Saponins (including alpha-hederin) ~0.1–0.5%. Flavonoids including quercetin, kaempferol, and their glycosides. Crude alkaloid content ~0.01–0.2%. BIOAVAILABILITY NOTES: Thymoquinone has low oral bioavailability (~5–10% in animal models) due to extensive first-pass metabolism and poor aqueous solubility (log P ~2.5); encapsulation in nanoparticles, nanoemulsions, or co-consumption with dietary fat substantially improves absorption. Mineral bioavailability may be partially reduced by phytic acid content (~1.5–2.5%), though traditional roasting or grinding may mitigate this. Fat-soluble bioactives are best absorbed when seeds are consumed with lipid-containing meals. Protein digestibility is moderate (~70–80% IVPD), comparable to other oilseeds.

Preparation & Dosage

No clinically studied dosage ranges were provided in the research dossier for any form of Nigella sativa (extract, powder, or standardized preparations). Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Insufficient research data to recommend synergistic ingredients

Safety & Interactions

Nigella sativa is generally well tolerated at culinary doses, but supplemental doses (above 2–3 g/day of oil) may cause gastrointestinal upset, nausea, or bloating in some individuals. Thymoquinone has demonstrated inhibition of cytochrome P450 enzymes CYP3A4 and CYP2D6 in vitro, raising a theoretical risk of elevated plasma levels of drugs metabolized by these pathways, including certain statins, anticoagulants, and antidepressants. Black seed oil may potentiate anticoagulant and antiplatelet medications such as warfarin or aspirin, increasing bleeding risk, and should be used with caution in patients on blood thinners. Pregnancy safety is not established; animal studies suggest high doses may stimulate uterine contractions, so use during pregnancy is not recommended without medical supervision.